263 related articles for article (PubMed ID: 22773541)
1. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy.
Hashizume A; Katsuno M; Banno H; Suzuki K; Suga N; Mano T; Atsuta N; Oe H; Watanabe H; Tanaka F; Sobue G
Brain; 2012 Sep; 135(Pt 9):2838-48. PubMed ID: 22773541
[TBL] [Abstract][Full Text] [Related]
2. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.
Atsuta N; Watanabe H; Ito M; Banno H; Suzuki K; Katsuno M; Tanaka F; Tamakoshi A; Sobue G
Brain; 2006 Jun; 129(Pt 6):1446-55. PubMed ID: 16621916
[TBL] [Abstract][Full Text] [Related]
3. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
Suzuki K; Katsuno M; Banno H; Takeuchi Y; Atsuta N; Ito M; Watanabe H; Yamashita F; Hori N; Nakamura T; Hirayama M; Tanaka F; Sobue G
Brain; 2008 Jan; 131(Pt 1):229-39. PubMed ID: 18056738
[TBL] [Abstract][Full Text] [Related]
4. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy.
Takeuchi Y; Katsuno M; Banno H; Suzuki K; Kawashima M; Atsuta N; Ito M; Watanabe H; Tanaka F; Sobue G
Muscle Nerve; 2008 Aug; 38(2):964-71. PubMed ID: 18642379
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
6. A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy.
Kosaka T; Miyajima A; Kikuchi E; Takahashi S; Suzuki N; Oya M
J Androl; 2012; 33(4):563-5. PubMed ID: 21940987
[TBL] [Abstract][Full Text] [Related]
7. Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene.
Praline J; Guennoc AM; Malinge MC; de Toffol B; Corcia P
Amyotroph Lateral Scler; 2008 Feb; 9(1):40-2. PubMed ID: 17852020
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Genotype-Phenotype Correlation of Korean Patients with Spinal and Bulbar Muscular Atrophy.
Song JS; Kim KA; Min JH; Ki CS; Kim JW; Sung DH; Kim BJ
Yonsei Med J; 2015 Jul; 56(4):993-7. PubMed ID: 26069122
[TBL] [Abstract][Full Text] [Related]
9. The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy.
Suzuki K; Katsuno M; Banno H; Takeuchi Y; Kawashima M; Suga N; Hashizume A; Hama T; Uchida K; Yamashita F; Nakamura T; Hirayama M; Tanaka F; Sobue G
J Neurol Neurosurg Psychiatry; 2010 May; 81(5):567-71. PubMed ID: 19965845
[TBL] [Abstract][Full Text] [Related]
10. Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.
Grunseich C; Kats IR; Bott LC; Rinaldi C; Kokkinis A; Fox D; Chen KL; Schindler AB; Mankodi AK; Shrader JA; Schwartz DP; Lehky TJ; Liu CY; Fischbeck KH
Neuromuscul Disord; 2014 Nov; 24(11):978-81. PubMed ID: 25047668
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy.
Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Tanaka F; Sobue G
Muscle Nerve; 2012 Nov; 46(5):692-7. PubMed ID: 22941760
[TBL] [Abstract][Full Text] [Related]
12. [Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].
Li XH; Zhuang JJ; Xie QY; Li AP; Liang XL; Feng YQ; Fang YY; Li JR; Liang YX
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1611-5. PubMed ID: 17803850
[TBL] [Abstract][Full Text] [Related]
13. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
14. CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.
Sułek A; Hoffman-Zacharska D; Krysa W; Szirkowiec W; Fidziańska E; Zaremba J
J Appl Genet; 2005; 46(2):237-9. PubMed ID: 15876692
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
[TBL] [Abstract][Full Text] [Related]
16. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the lengths of androgen receptor triplet repeats in brain and blood in motor neuron diseases.
Saunderson RB; Yu B; Trent RJ; Pamphlett R
J Neurol Sci; 2008 Apr; 267(1-2):125-8. PubMed ID: 17997416
[TBL] [Abstract][Full Text] [Related]
18. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
[TBL] [Abstract][Full Text] [Related]
19. [Multiple phenotypic manifestations of X-linked spinobulbar muscular atrophy].
Vandenberghe N; Bouhour F; Petiot P; Gonnaud PM; Latour P; Broussolle E; Vial C
Rev Neurol (Paris); 2009 Jan; 165(1):31-7. PubMed ID: 18667219
[TBL] [Abstract][Full Text] [Related]
20. Natural history of spinal-bulbar muscular atrophy.
Chahin N; Klein C; Mandrekar J; Sorenson E
Neurology; 2008 May; 70(21):1967-71. PubMed ID: 18490617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
